Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study

Journal of Nutrition

Volumn 146, Issue 2, 2016, Pages 427S-432S

  Matsumoto, Suguru ^a   Nakanishi, Rine ^a   Li, Dong ^a   Alani, Anas ^a   Rezaeian, Panteha ^a   Prabhu, Sach ^b   Abraham, Jeby ^a   Fahmy, Michael A ^a   Dailing, Christopher ^a   Flores, Ferdinand ^a   Hamal, Sajad ^a   Broersen, Alexander ^c   Kitslaar, Pieter H ^c,d   Budoff, Matthew J ^a  

^a UCLA MEDICAL CENTER   (United States)

^b Mercy Medical Center   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Medis Medical Imaging Systems bv   (Netherlands)

Author keywords

Atherosclerosis; Cardiac ct; Garlic; Progression; Randomized trial

Indexed keywords

ACETYLSALICYLIC ACID; AGED GARLIC EXTRACT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GARLIC EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CALCIUM; PLANT EXTRACT;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; CORONARY BLOOD VESSEL; DISEASE COURSE; DRUG EFFECTS; GARLIC; METABOLISM; PATHOLOGY; PHYTOTHERAPY; PLAQUE, ATHEROSCLEROTIC; RISK FACTOR;

CALCIUM; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GARLIC; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84959289031     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.202424     Document Type: Article

References (30)

1. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, Gill T, Ruffin R. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005;28:2777-9.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288: 2709-16.
3. Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O'Donnell CJ, Wang TJ, et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007;56:1718-26.
4. Expert panel on detection evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
5. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-90.
6. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr 2006;136(3, Suppl)736S-40S.
7. Larijani VN, Ahmadi N, Zeb I, Khan F, Flores F, BudoffM. Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial. Nutrition 2013;29:71-5.
8. BudoffMJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, Rosen RT, Amagase H. Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med 2004;39:985-91.
9. BudoffMJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, Takasu J, Miller E, Tsimikas S. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009; 49:101-7.
10. de Graaf MA, Broersen A, Kitslaar PH, Roos CJ, Dijkstra J, Lelieveldt BP, Jukema JW, Schalij MJ, Delgado V, Bax JJ, et al. Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology. Int J Cardiovasc Imaging 2013;29:1177-90.
11. BudoffMJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 2008; 52:1724-32.
12. Papadopoulou SL, Neefjes LA, Garcia-Garcia HM, Flu WJ, Rossi A, Dharampal AS, Kitslaar PH, Mollet NR, Veldof S, Nieman K, et al. Natural history of coronary atherosclerosis by multislice computed tomography. JACC Cardiovasc Imaging 2012;5(3, Suppl)S28-37.
13. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, Naruse H, Ishii J, Hishida H, Wong ND, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.
14. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013;34:719-28.
15. Mao SS, Li D, Rosenthal DG, Cerilles M, Zeb I, Wu H, Flores F, Gao Y, BudoffMJ. Dual-standard reference values of left ventricular volumetric parameters by multidetector CT angiography. J Cardiovasc Comput Tomogr 2013;7:234-40.
16. RaffGL, Abidov A, Achenbach S, Berman DS, Boxt LM, BudoffMJ, Cheng V, DeFrance T, Hellinger JC, Karlsberg RP, et al. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr 2009;3:122-36.
17. Dalager MG, Bøttcher M, Andersen G, Thygesen J, Pedersen EM, Dejbjerg L, Gøtzsche O, Bøtjer HE. Impact of luminal density on plaque classification by CT coronary angiography. Int J Cardiovasc Imaging 2011;27:593-600.
18. Motoyama S, Kondo T, Anno H, Sugiura A, Ito Y, Mori K, Ishii J, Sato T, Inoue K, Sarai M, et al. Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J 2007;71: 363-6.
19. Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T, Tardif JC, Serruys PW. Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 2011;6: 1123-30, 9.
20. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-35.
21. Nakanishi R, Min JK. Coronary CT angiographic measures of adverse atherosclerotic plaque features. Curr Cardiovasc Risk Rep 2013;7: 117-25.
22. Inoue K, Motoyama S, Sarai M, Sato T, Harigaya H, Hara T, Sanda Y, Anno H, Kondo T, Wong ND, et al. Serial coronary CT angiographyverified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 2010;3:691-8.
23. Zeb I, Li D, Nasir K, Malpeso J, Batool A, Flores F, Dailing C, Karlsberg RP, BudoffM. Effect of statin treatment on coronary plaque progression-a serial coronary CT angiography study. Atherosclerosis 2013;231:198-204.
24. Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994;29:189-93.
25. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001;161:813-24.
26. Sendl A, Elbl G, Steinke B, Redl K, Breu W, Wagner H. Comparative pharmacological investigations of Allium ursinum and Allium sativum. Planta Med 1992;58:1-7.
27. Kim-Park S, Ku DD. Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol 2000;27:780-6.
28. Ide N, Keller C, Weiss N. Aged garlic extract inhibits homocysteineinduced CD36 expression and foam cell formation in human macrophages. J Nutr 2006;136(3, Suppl)755S-8S.
29. Dillon SA, Burmi RS, Lowe GM, Billington D, Rahman K. Antioxidant properties of aged garlic extract: an in vitro study incorporating human low density lipoprotein. Life Sci 2003;72: 1583-94.
30. Fahmy M, Nakanishi R, Matsumoto S, Alani A, Abraham J, Hamal S, Li D, Daling C, Flores F, Broersen A. Inter-observer Reproducibility in a Novel Semi-Automated Coronary Plaque Quantification Software. J Cardiovasc Comput Tomogr 2014;8(3, Suppl)S57.